AIDS Vaccine Advocacy Coalition (AVAC)

Oral Pre-exposure Prophylaxis–Questions and Answers

- Released in
Implementing PrEP poses new challenges in planning, managing and funding combination prevention. Realizing the promise of PrEP will require governments, funders, civil society and other stakeholders to join forces to systematically address them–licensing antiretroviral medicines for PrEP use, setting priorities for locations and populations for implementation, making services user-friendly and ensuring adherence.

Px Wire: A Quarterly Update on HIV Prevention Research (January-March 2016)

- Released in
In late 2015, UNAIDS issued long-awaited HIV prevention targets, including a call for a total of 27 million additional voluntary medical male circumcision (VMMC) procedures by 2020. This works out to more than five million procedures per year on average—two million more than have ever been performed.

AVAC Report 2017: Mixed Messages and How to Untangle Them

- Released in

In this year's AVAC Report—Mixed Messages and How to Untangle Them—we have set ourselves the task of clarifying the profoundly complex field of biomedical HIV prevention and research. This is never an easy task, but it is made all the more complicated— and exciting—in the current environment.

HIV Vaccines: Key Messages

- Released in
An HIV vaccine is both possible and essential. Existing options for prevention and treatment must be scaled up to bring down rates of new infections, but a vaccine is an essential component of a long-term end to the HIV epidemic.

Advocacy in Uncertain Times: A Call to Action

- Released in
An epidemic can be controlled with treatment and other prevention—just as HIV is coming under control today. But a sustained end has almost always depended on a vaccine. This year on HIV Vaccine Awareness Day, our core message is simple: No end without a vaccine; no vaccine without funding.

AVAC Report 2019: Now What?

- Released in

Each year, the AVAC Report frames the most pressing advocacy issues facing the HIV response. At the threshold of 2020, it’s clear that global goals for HIV prevention will miss the mark by a long shot. Though important progress has been made, the crisis UNAIDS called out in 2016 persists today with new infections around 1.7 million annually, a far cry from the 2020 target of fewer than 500,000. So, we asked ourselves, Now What?, and answered with cross-cutting analysis and an advocacy agenda to match.

Subscribe to AIDS Vaccine Advocacy Coalition (AVAC)